- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 5/46 - Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
Patent holdings for IPC class A61P 5/46
Total number of patents in this class: 69
10-year publication summary
|
1
|
5
|
3
|
6
|
7
|
3
|
3
|
3
|
6
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Corcept Therapeutics, Inc. | 370 |
10 |
| Oric Pharmaceuticals, Inc. | 85 |
7 |
| Daiichi Sankyo Company, Limited | 1891 |
4 |
| Sparrow Pharmaceuticals, Inc. | 23 |
3 |
| Boehringer Ingelheim International GmbH | 4483 |
2 |
| Boehringer Ingelheim Pharma GmbH & Co. Kg | 366 |
2 |
| Bayer Intellectual Property GmbH | 2357 |
2 |
| Astellas US LLC | 168 |
2 |
| Bioniche Life Sciences Inc. | 7 |
2 |
| Jiangsu Simcere Pharmaceutical Co., Ltd | 126 |
2 |
| University of Ottawa | 240 |
2 |
| Propella Therapeutics, Inc. | 8 |
2 |
| Novartis AG | 10178 |
1 |
| AstraZeneca AB | 2824 |
1 |
| Merck Patent GmbH | 5735 |
1 |
| Bayer Pharma AG | 1010 |
1 |
| Amgen Inc. | 4436 |
1 |
| The Regents of the University of Michigan | 5012 |
1 |
| The Johns Hopkins University | 5907 |
1 |
| BioMarin Pharmaceutical Inc. | 397 |
1 |
| Other owners | 21 |